Hutch News
Results per Page:
New projects advance health equity research
Two $1M grants support efforts to pinpoint novel prostate cancer biomarkers, improve clinical trial enrollment and inclusion
A Journey Through Our Genes: The Story of Prostate Cancer's Hidden Secrets
From the Darst research group, Public Health Sciences Division
How do we increase equity in cancer care?
HICOR’s Value in Cancer Care Summit brings together stakeholders to discuss barriers, pain points and solutions
BRCA-mutation researcher Dr. Rosevalentine Bosire named Brave Fellow
In memory of runner Gabe Grunewald, research at Fred Hutch will inform new treatments for rare and aggressive cancers
The Beam: Janice Kim speaks about breast cancer, meet our new doctor, healthy fall foods
Our expert weighs in on breast cancer, we introduce our new physician, T. Martin Ma, MD, PhD, and showcase healthy food for fall.
Cancer care: From ‘sledgehammer’ to precision cellular therapy
AACR progress report: new immunotherapies improve outcomes, but access to care and clinical trials for many still lags
Wildlife photographer Kevin Murphy chooses proton therapy for prostate cancer
Kevin watched and waited seven years with low-grade prostate cancer. When it was time for treatment, he chose proton therapy.
Focusing on prostate cancer treatment without surgery
HIFU therapy offers alternative for one-third of patients, including Bothell’s Ken Cleary
Does prostate cancer have a goldilocks mentality when it comes to androgens?
From the Nelson lab, Human Biology and Clinical Research Divisions
RNA stability may play a role in prostate cancer
New research links mutations in RNA region that helps regulate protein production to progression and drug resistance
Interrogating heterogeneous PSMA expression in advanced prostate cancer
From the Haffner Lab, Human Biology Division
Known variant vs. genome wide: which PRS is better for prostate cancer?
From the Darst Lab, Public Health Sciences Division
Boost and attack approach for metastatic prostate cancer therapy!
From the Lee Lab, Human Biology and Clinical Research Divisions, Cancer Consortium
Improving immunotherapy for advanced prostate cancer
Preclinical work identifies better target and recruits more immune cells to make CAR-T therapy work for solid tumors
Classifying prostate cancer subtypes from liquid biopsies
From the Ha and Nelson labs, Human Biology Division
Racial inequalities in prostate cancer treatment among Medicare beneficiaries
From Dr. Yaw Nyame, Fred Hutch Public Health Sciences Division and the University of Washington